It was recently demonstrated that a hematogenous route for medulloblastoma leptomeningeal metastases is active, and the C-C Motif Chemokine Ligand 2 (CCL2) production by tumor cells play a pivotal role in such an occurrence. This evidence concerns the gene CCL2 and neoplasm.